Dendreon Corp. has received great news from the FDA about their pending application for the approval of Provenge. STILL TIME TO SIGN PATIENT PETITION TO FDA FOR PROSTATE CANCER TREATMENT APPROVAL and Provengenow news-- Click Here NEW YORK (Dow Jones)--Dendreon Corp. (DNDN) Thursday said the Food and Drug Administration would accept interim trial data to [...]
There are three more day's to put your name forward and sign up to show your support for men with advanced prostate cancer. Even though the Food and Drug Administration is a United States Government agency, it's decisions affect prostate cancer treatment throughout the world. Dr George Cooper has written an excellent letter of understanding [...]
In today’s Wall Street Journal there is a fantastic opinion piece written by Dr. Mark Thornton, Black Wednesday at the FDA. Dr. Thornton points out that not only did the FDA not approve Provenge last Wednesday, but also it failed to approve Junovan, a immunological drug designed to treat young children with a rare bone [...]
The Wall Street Journal's health blog has exploded with comments about the recent article about the FDA and Provenge. Their piece along with the comments are a must read. You can see the blog at: The Wall Street Journal Health Blog Please don't forget to www.malecare.com and sign our letter to the FDA. Our letter [...]
There is a sign on action letter to the FDA regarding it's CR letter on Provenge, at www.malecare.com Please take a look and if you agree, sign on. Also, please help get the word out about this, as we will mail this letter and its signatories on May 18, 2007.